Search Results - "Wong, Z.W"

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial by J. Lee, A. Dean, T. Price, K. Sjoquist, V. Gebski, J. Mumford, F. Day, S. Yip, K. Wilson, C. Jackson, S. Padinharakam, B. Lee, M. Burge, D. Siu, C. Karapetis, L. Chantrill, Z.W. Wong, R. Jennens, C. Lomma, A. Franscesconi, S. Ackland, J. Lynam, S. Wahlroos, J. So, M. Jameson, N. Tebbutt, S. Gill, D. Grimes, C. Steer, M. Harris

“…Background: The dense stroma of pancreatic ductal adenocarcinoma (PDAC) is thought to impede tumour drug delivery. LSTA1, a novel cyclic tumour-penetrating…”
Get full text

Correlation Between Changes in End-Tidal Carbon Dioxide Concentration and Cardiac Output During Inferior Vena Cava Clamping and Unclamping in Living-donor Liver Transplantation by Shih, T.H, Huang, C.E, Chen, C.L, Wang, C.H, Huang, C.J, Cheng, K.W, Wu, S.C, Juang, S.E, Lee, Y.E, Wong, Z.W, Jawan, B, Yang, S.C

“…Abstract Background To test the hypothesis that low end-tidal carbon dioxide tension encountered during anhepatic phase in liver transplantation is related to…”
Get full text

Retrospective Cohort Study to Compare Anesthesia in Living Donor Liver Transplantation Recipients Who Received Single and Dual Liver Grafts by Cheng, K.W, Ma, C.W, Chen, C.L, Wang, C.H, Huang, C.J, Shih, T.H, Yang, S.C, Juang, S.E, Lee, Y.E, Wong, Z.W, Jawan, B, Huang, C.E, Wu, S.C

“…Abstract Objective Dual graft living donor liver transplantation (LDLT) is an alternative way to overcome small-for-size syndrome in LDLT. Surgical technique…”
Get full text

273MO A supportive and expanding nurse led model of care, symptom urgent review clinic (SURC) by Taylor, L., Poole, W., Wong, Z.W.

Get full text

Propensity for seizure-related cortical laminar necrosis in hepatic encephalopathy by Peters, James, Vijiaratnam, Nirosen, Wong, Joseph Z.W., Jitpiriyaroj, Sonia, Chandra, Ronil V., Kempster, Peter A.

“…•Hepatic encephalopathy may predispose to seizure-related cortical laminar necrosis.•Elevated ammonia levels potentially compound the excitotoxic effects of…”
Get full text

465P Oncological care needs of people with mental illness: A single institution experience in Australia by Yeoh, H.L., Holmes, C., Leong, M., Courts, K., Potasz, N., Lundy, J., Wong, Z.W., Newton, R., Antill, Y.

Get full text

809 Prediction of lymph node metastases in small T1 breast cancers by expression profiling by Lee, A, Chua, J.M, Tongyoo, P, Yong, W.S, Ho, G.H, Koong, H.N, Ang, P, Teh, B.T, Wong, Z.W

Get full text

110P Clinical validation of a 50-gene hotspot NGS panel in Asian patients with solid tumors by Lim, D., Teo, S., Toh, Y.L., Law, C.W., Wong, J., Yau, X.W., Wong, Z.W., Li, Y., Tan, C.K., Chan, M., Tan, S.Y.

Get full text

Complete response of metastatic pleomorphic dermal sarcoma to anti‐PD‐1 therapy by Klein, O., McTigue, C., Wong, Z.W., Syme, D.B., Hunter‐Smith, D.J.

Get full text

2086 POSTER Clinical implications of the MDR1 1236C>T polymorphism: influences on doxorubicin pharmacokinetics and myelosupression in Asian breast cancer patients by Wong, Z.W, Lal, S, Ang, P.C.S, See, H.T, Wong, N.S, Chia, J.W.K, Yap, Y.S, Khoo, K.S, Chowbay, B

Get full text

1496PATTITUDES OF PHYSICIANS TOWARD RISK ASSESSMENT AND USE OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) AS PRIMARY PROPHYLAXIS (PP) IN PATIENTS (PTS) RECEIVING CHEMOTHERAPY WITH AN INTERMEDIATE RISK OF FEBRILE NEUTROPENIA (FN) by Freyer, G., Kalinka-Warzocha, E., Syrigos, K., Marinca, M., Tonini, G., Ng, S.L., Wong, Z.W., Salar, A., Steger, G.G., Abdelsalam, M., Decosta, L., Szabo, Z.

“…Abstract Aim: For chemotherapy regimens with intermediate FN risk (10–20%), physicians should assess patient risk factors to determine whether overall risk is…”
Get full text

Attitudes of Physicians Toward Risk Assessment and Use of Granulocyte-Colony Stimulating Factor (G-Csf) As Primary Prophylaxis (Pp) in Patients (Pts) Receiving Chemotherapy with an Intermediate Risk of Febrile Neutropenia (Fn) by Freyer, G., Kalinka-Warzocha, E., Syrigos, K., Marinca, M., Tonini, G., Ng, S.L., Wong, Z.W., Salar, A., Steger, G.G., Abdelsalam, M., Decosta, L., Szabo, Z.

Get full text

Multimodality treatment for stage III non small cell lung cancer by Foo, K.F, Tan, E.H, Leong, S.S, Agasthian, T, Fong, K.W, Wee, J, Ong, S, Ang, P, Tay, M.H, See, H.T, Wong, Z.W, Hsu, L.Y, Eng, P

Get full text

Concurrent chemotherapy and radiotherapy in the treatment of unresectable stage III non-small cell lung cancer by Leong, S.S, Ong, Y.K, Fong, K.W, Lee, K.M, Wee, J, Foo, K.F, Ang, P, Tay, M.H, See, H.T, Wong, Z.W, Tan, E.H

Get full text

Phase II trial of sequential gemcitabine followed by cisplatin in patients with advanced non small cell lung cancer by Foo, K.F, Leong, S.S, Ang, P, See, H.T, Ong, S, Wee, J, Fong, K.W, Machin, D, Tay, M.H, Wong, Z.W, Tan, E.H

Get full text